Your browser doesn't support javascript.
loading
Comparison of Surgical Site Infection After Instrumented Spine Surgery in Patients With High Risk of Infection According to Different Antibiotic Prophylaxis Protocols: A Cohort Study of 132 Patients With a Minimum Follow-Up of 1 year.
Ferrer Pomares, Pierre; Duque Santana, Pablo; Moreno Mateo, Fernando; Mengis Palleck, Charles L; Tomé Bermejo, Felix; Álvarez Galovich, Luis.
Afiliação
  • Ferrer Pomares P; Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Duque Santana P; Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Moreno Mateo F; Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Mengis Palleck CL; Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Tomé Bermejo F; Department of Orthopaedic and Trauma Surgery, General University Hospital of Villalba, Madrid, Spain.
  • Álvarez Galovich L; Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Global Spine J ; : 21925682241270097, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-39089872
ABSTRACT
STUDY

DESIGN:

Observational Study.

OBJECTIVES:

Surgical site infections (SSIs) are one of the major complications in spine surgery. Numerous factors that increase the risk of SSI have been widely described. However, clinical guidelines on antibiotic prophylaxis are usually common for all patients. There are no specific guidelines for patients with a high risk of infection. The aim of this paper is to create a specific protocol for patients at high risk of SSI.

METHODS:

This is a three-cohort study using a prospective database. Risk patients are those who meet at least two of the following criteria obesity, diabetes, reoperation and immunosuppression. Between October 2021 and April 2023, 132 patients were recruited.They were divided into three cohorts cohort A, 46 patients, standard prophylaxis with cefazolin 2 g/8 h for 24 h; cohort B, 46 patients, cefazolin 2 g/8h and amikacin 500 mg/12 h for 24 h; cohort C, 40 patients, cefazolin 2 g/8h and amikacin 500 mg/12 h for 72 h.

RESULTS:

There was a significant decrease in the infection rate depending on the prophylaxis (23.9% in cohort A, 8.7% in cohort B, and 2.5% in cohort C). When logistic regression models were applied and cohorts B and C were compared with A, the following results were obtained OR of 0.30 (CI 0.08 - 0.97; P = 0.057) and 0.08 (IC 0.00 - 0.45; P = 0.019), respectively.

CONCLUSIONS:

Prophylaxis with prolonged double antibiotic therapy with cefazolin and amikacin is associated with a statistically significant decrease in the rate of SSI in patients with a high risk of infection.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article